Back to ACAD
RHODES INVESTMENT ADVISORS INC /ADV → ACAD
RHODES INVESTMENT ADVISORS INC /ADV ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
4
Latest value
$1.2M
Q3 2026
Peak value
$1.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1M |
| Q1 2026 | $949K |
| Q2 2026 | $1.1M |
| Q3 2026 | $1.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.2M | 6.7K | — | — |
| Q2 2026 | $1.1M | 6.3K | — | — |
| Q1 2026 | $949K | 5.8K | — | — |
| Q4 2025 | $1M | 5.8K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M